Scott-Wittenborn Nicholas, Jackson Ryan S
Department of Otolaryngology, Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Department of Otolaryngology, Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, United States.
Am J Otolaryngol. 2018 Mar-Apr;39(2):220-222. doi: 10.1016/j.amjoto.2017.09.001. Epub 2017 Sep 6.
The purpose of this study was to determine if the use of the FIREFLY imaging system could be an asset in transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC). The system uses indocyanine green dye (ICG), which fluoresces when illuminated by near-infrared light from the Da Vinci robot. The system may improve visualization of tumor margins, highlight important vascular structures, and help identify the location of tumors and unknown primary head and neck cancers.
Six patients with OPSCC were enrolled in the study. Two of these cases were unknown primaries, one was base of tongue, and three were palatine tonsils. Each patient was given two 3ml doses of ICG, one at the beginning of the surgical case and one during resection of the tumor. The oropharynx was then visualized using the near-infrared light of the Da Vinci robot for a minute after injection.
The FIREFLY system was unable to detect gross tumors, positive margins, unknown primaries, or vascular structures in any of the six subjects in the study. In addition, there were no adverse events or side effects in any of the subjects.
The use of the FIREFLY system with indocyanine green fluorescence did not identify tumor boundaries, unknown primary head and neck cancers, or vascular structures in the oropharynx.
本研究的目的是确定萤火虫成像系统在口咽鳞状细胞癌(OPSCC)的经口机器人手术(TORS)中是否具有优势。该系统使用吲哚菁绿染料(ICG),当受到达芬奇机器人发出的近红外光照射时会发出荧光。该系统可能会改善肿瘤边缘的可视化,突出重要的血管结构,并有助于确定肿瘤以及不明原发灶头颈癌的位置。
6例口咽鳞状细胞癌患者纳入本研究。其中2例为不明原发灶,1例为舌根癌,3例为腭扁桃体癌。每位患者均给予两剂3ml的ICG,一剂在手术开始时注射,另一剂在肿瘤切除期间注射。注射后,使用达芬奇机器人的近红外光对口咽进行一分钟的可视化观察。
萤火虫系统在本研究的6名受试者中均无法检测到肉眼可见的肿瘤、阳性切缘、不明原发灶或血管结构。此外,所有受试者均未出现不良事件或副作用。
使用带有吲哚菁绿荧光的萤火虫系统无法识别口咽中的肿瘤边界、不明原发灶头颈癌或血管结构。